Literature DB >> 19214450

Triple coronary artery bypass graft in a 10-year-old child with familial hypercholesterolemia.

Mohammad Hassan Nemati1, Behrooz Astaneh, Afshad Joubeh.   

Abstract

Familial hypercholesterolemia is a genetic disorder caused by a mutation in the low density lipoprotein (LDL) receptor gene. The homozygous type of the disease is rare and causes tendon xanthomas and coronary artery disease during the early years of life. Herein we present a 10-year-old child with familial hypercholesterolemia who had three-vessel disease and was a candidate for liver transplantation. To the best of our knowledge, he is one of the youngest such patients reported in the English-language literature who underwent coronary artery bypass surgery.

Entities:  

Mesh:

Year:  2009        PMID: 19214450     DOI: 10.1007/s11748-008-0335-7

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  10 in total

1.  Coronary revascularization in seven-year-old boy with homozygous familial hypercholesterolaemia.

Authors:  U Ersoy; M Güvener
Journal:  Acta Paediatr       Date:  2000-12       Impact factor: 2.299

2.  Total arterial revascularization in a child with familial homozygous hypercholesterolemia.

Authors:  Anil Bhan; Sunil Swain; R Juneja; P Saxena; P Venugopal
Journal:  J Thorac Cardiovasc Surg       Date:  2005-04       Impact factor: 5.209

3.  Saphenous vein graft growth 13 years after coronary bypass in a child with Kawasaki disease.

Authors:  H M El-Khouri; D A Danilowicz; A J Slovis; S B Colvin; M Artman
Journal:  Ann Thorac Surg       Date:  1998-04       Impact factor: 4.330

4.  Familial hypercholesterolemia in a paediatric patient.

Authors:  Maad Ullah; Syed Afzaal Ahmad
Journal:  J Coll Physicians Surg Pak       Date:  2005-09       Impact factor: 0.711

5.  Triple coronary bypass in a child with homozygous familial hypercholesterolemia.

Authors:  Mehmet Salih Bilal; Numan Ali Aydemir; Nihat Cine; Ahmet Celebi; Mehmet Kaplan
Journal:  Heart Surg Forum       Date:  2005       Impact factor: 0.676

6.  Coronary artery bypass surgery with arterial grafts in familial hypercholesterolemia.

Authors:  M Kawasuji; N Sakakibara; S Fujii; T Yasuda; Y Watanabe
Journal:  J Thorac Cardiovasc Surg       Date:  2000-05       Impact factor: 5.209

Review 7.  Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review.

Authors:  Melissa A Austin; Carolyn M Hutter; Ron L Zimmern; Steve E Humphries
Journal:  Am J Epidemiol       Date:  2004-09-01       Impact factor: 4.897

8.  Long-term survival of childhood coronary artery disease in a patient severely affected with familial hypercholesterolemia.

Authors:  Christopher Sibley; Sarah McGann; Neil J Stone
Journal:  Am J Cardiol       Date:  2004-09-01       Impact factor: 2.778

9.  Long-term appraisal of coronary bypass operations in familial hypercholesterolemia.

Authors:  T Takahashi; S Nakano; Y Shimazaki; M Kaneko; N Hirata; T Nakamura; Y Matsuzawa; S Kitamura; H Matsuda
Journal:  Ann Thorac Surg       Date:  1993-09       Impact factor: 4.330

10.  Family history and cardiovascular risk in familial hypercholesterolemia: data in more than 1000 children.

Authors:  Albert Wiegman; Jessica Rodenburg; Saskia de Jongh; Joep C Defesche; Henk D Bakker; John J P Kastelein; Eric J G Sijbrands
Journal:  Circulation       Date:  2003-03-25       Impact factor: 29.690

  10 in total
  8 in total

1.  Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia-target attainment requires further increase of intensity.

Authors:  Günter Klaus; Christina Taylan; Rainer Büscher; Claus Peter Schmitt; Lars Pape; Jun Oh; Joenna Driemeyer; Matthias Galiano; Jens König; Carsten Schürfeld; Ralf Spitthöver; Juergen R Schaefer; Lutz T Weber; Andreas Heibges; Reinhard Klingel
Journal:  Pediatr Nephrol       Date:  2018-03-03       Impact factor: 3.714

Review 2.  Optimal management of familial hypercholesterolemia: treatment and management strategies.

Authors:  Mohammad Hassan Nemati; Behrooz Astaneh
Journal:  Vasc Health Risk Manag       Date:  2010-12-03

3.  Cohort Generation and Characterization of Patient-Specific Familial Hypercholesterolemia Induced Pluripotent Stem Cells.

Authors:  Linda Omer; Elizabeth A Hudson; Lisa C Hudgins; Nolan L Boyd
Journal:  Stem Cells Dev       Date:  2021-05-21       Impact factor: 4.390

4.  A Case of Severe Carotid Stenosis in a Patient with Familial Hypercholesterolemia without Significant Coronary Artery Disease.

Authors:  Marcos Aurélio Lima Barros; Hygor Ferreira-Fernandes; Ingrid Cristina Rêgo Barros; Adriel Rêgo Barbosa; Giovanny Rebouças Pinto
Journal:  Case Rep Cardiol       Date:  2014-10-23

Review 5.  The Effect of Mipomersen in the Management of Patients with Familial Hypercholesterolemia: A Systematic Review and Meta-Analysis of Clinical Trials.

Authors:  Behrooz Astaneh; Nima Makhdami; Vala Astaneh; Gordon Guyatt
Journal:  J Cardiovasc Dev Dis       Date:  2021-07-20

6.  Redux valvular surgery with coronary artery bypass graft in familial hypercholesterolemia.

Authors:  Ziadi Jalel; Mleyhi Sobhi; Ben Omrane Skander; Khayati Adel
Journal:  Ann Pediatr Cardiol       Date:  2014-01

7.  The Genetic Spectrum of Familial Hypercholesterolemia (FH) in the Iranian Population.

Authors:  R H Fairoozy; M Futema; R Vakili; M R Abbaszadegan; S Hosseini; M Aminzadeh; H Zaeri; M Mobini; S E Humphries; A Sahebkar
Journal:  Sci Rep       Date:  2017-12-06       Impact factor: 4.379

Review 8.  State-of-the-Art Pediatric Coronary Artery Bypass Surgery: a Literature Review.

Authors:  Roman Komarov; Alisher Ismailbaev; Vagi Chragyan; Bakytbek Kadyraliev; Michel Pompeu B O Sá; Arjang Ruhparwar; Alexander Weymann; Konstantin Zhigalov
Journal:  Braz J Cardiovasc Surg       Date:  2020-08-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.